ATE332706T1 - Verwendung von hyaluronidase zur herstellung eines arzneimittels zur behandlung von entzündungen - Google Patents
Verwendung von hyaluronidase zur herstellung eines arzneimittels zur behandlung von entzündungenInfo
- Publication number
- ATE332706T1 ATE332706T1 AT98921978T AT98921978T ATE332706T1 AT E332706 T1 ATE332706 T1 AT E332706T1 AT 98921978 T AT98921978 T AT 98921978T AT 98921978 T AT98921978 T AT 98921978T AT E332706 T1 ATE332706 T1 AT E332706T1
- Authority
- AT
- Austria
- Prior art keywords
- hyaluronidase
- treatment
- inflammation
- production
- medicinal product
- Prior art date
Links
- 108010003272 Hyaluronate lyase Proteins 0.000 title abstract 3
- 102000001974 Hyaluronidases Human genes 0.000 title abstract 3
- 229960002773 hyaluronidase Drugs 0.000 title abstract 3
- 206010061218 Inflammation Diseases 0.000 title abstract 2
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 abstract 1
- 229940099552 hyaluronan Drugs 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 230000008595 infiltration Effects 0.000 abstract 1
- 238000001764 infiltration Methods 0.000 abstract 1
- 210000004969 inflammatory cell Anatomy 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702657A SE512633C2 (sv) | 1997-07-09 | 1997-07-09 | Användning av hyaluronidas för reduktion av inflammatoriska cellinfiltrat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE332706T1 true ATE332706T1 (de) | 2006-08-15 |
Family
ID=20407703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98921978T ATE332706T1 (de) | 1997-07-09 | 1998-05-06 | Verwendung von hyaluronidase zur herstellung eines arzneimittels zur behandlung von entzündungen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6572855B1 (de) |
| EP (1) | EP0994719B1 (de) |
| JP (1) | JP2002509542A (de) |
| AT (1) | ATE332706T1 (de) |
| AU (1) | AU741770B2 (de) |
| CA (1) | CA2296581A1 (de) |
| DE (1) | DE69835210T2 (de) |
| ES (1) | ES2267186T3 (de) |
| NO (1) | NO20000098L (de) |
| SE (1) | SE512633C2 (de) |
| WO (1) | WO1999002181A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10026666A1 (de) * | 2000-05-29 | 2001-12-20 | Gunther Burgard | Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen |
| US6682904B1 (en) * | 2002-08-15 | 2004-01-27 | Deliatroph Pharmaceuticals, Inc. | Specific inhibitors of hyaluronidase 2, and methods of identifying and using same |
| WO2004078140A2 (en) | 2003-03-05 | 2004-09-16 | Halozyme, Inc. | SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| WO2008149428A1 (ja) * | 2007-06-05 | 2008-12-11 | Glycoscience Laboratories, Inc. | 自己免疫疾患、炎症及び神経疾患の治療剤及び予防剤 |
| NZ601248A (en) | 2008-04-14 | 2014-06-27 | Halozyme Inc | Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
| US8784896B2 (en) | 2012-09-17 | 2014-07-22 | Biopep Solutions, Inc | Antioxidant therapy with a whole, leech saliva extract |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8504025D0 (en) * | 1985-02-16 | 1985-03-20 | Biopharm Ltd | Hyaluronidase |
| US5747027A (en) | 1995-04-07 | 1998-05-05 | The Regents Of The University Of California | BH55 hyaluronidase |
| US5958750A (en) | 1996-07-03 | 1999-09-28 | Inctye Pharmaceuticals, Inc. | Human hyaluronidase |
-
1997
- 1997-07-09 SE SE9702657A patent/SE512633C2/sv not_active IP Right Cessation
-
1998
- 1998-05-06 AT AT98921978T patent/ATE332706T1/de not_active IP Right Cessation
- 1998-05-06 WO PCT/SE1998/000831 patent/WO1999002181A1/en active IP Right Grant
- 1998-05-06 US US09/462,362 patent/US6572855B1/en not_active Expired - Fee Related
- 1998-05-06 JP JP50850999A patent/JP2002509542A/ja active Pending
- 1998-05-06 DE DE69835210T patent/DE69835210T2/de not_active Expired - Lifetime
- 1998-05-06 EP EP98921978A patent/EP0994719B1/de not_active Expired - Lifetime
- 1998-05-06 ES ES98921978T patent/ES2267186T3/es not_active Expired - Lifetime
- 1998-05-06 AU AU74618/98A patent/AU741770B2/en not_active Ceased
- 1998-05-06 CA CA002296581A patent/CA2296581A1/en not_active Abandoned
-
2000
- 2000-01-07 NO NO20000098A patent/NO20000098L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2296581A1 (en) | 1999-01-21 |
| SE9702657L (sv) | 1999-01-10 |
| SE512633C2 (sv) | 2000-04-17 |
| WO1999002181A1 (en) | 1999-01-21 |
| JP2002509542A (ja) | 2002-03-26 |
| EP0994719B1 (de) | 2006-07-12 |
| EP0994719A1 (de) | 2000-04-26 |
| AU7461898A (en) | 1999-02-08 |
| ES2267186T3 (es) | 2007-03-01 |
| AU741770B2 (en) | 2001-12-06 |
| DE69835210T2 (de) | 2007-07-05 |
| SE9702657D0 (sv) | 1997-07-09 |
| US6572855B1 (en) | 2003-06-03 |
| DE69835210D1 (de) | 2006-08-24 |
| NO20000098D0 (no) | 2000-01-07 |
| NO20000098L (no) | 2000-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59709414D1 (de) | Oxyiminopregnancarbolactone | |
| DE69726450D1 (de) | Mucosale verabreichung von wirkstoffen in säugern | |
| GB9807639D0 (en) | Anti-inflammatory agents | |
| TR199800415T1 (en) | Farmas�tik form�lasyon. | |
| SE9800806D0 (sv) | Användning av kollagenas | |
| AU582221B2 (en) | Process for producing natural heparan sulphate in substantially pure form,and their pharmaceutical use | |
| BG104726A (en) | Novel derivatives of the dihydroxyhexanoic acid | |
| DK0869965T3 (da) | Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler | |
| IT1269578B (it) | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base. | |
| ATE332706T1 (de) | Verwendung von hyaluronidase zur herstellung eines arzneimittels zur behandlung von entzündungen | |
| ES2170127T3 (es) | Sacarido no reductor, su produccion y su utilizacion. | |
| IT1263957B (it) | Impiego terapeutico del pirrolidon carbossilato di piridossina | |
| TR199900662T2 (xx) | 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m� | |
| DK0563256T3 (da) | Anvendelse af værtscelle-phospholipider til inhibering af bakteriekolonisering | |
| TR199801485T2 (xx) | Yeni 2,3 benzodiyazepin t�revleri, bu t�revlerin �retimi ve ila� olarak kullan�m�. | |
| YU17999A (sh) | Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu | |
| DE69715898D1 (de) | Verwendung von hyaluronidase | |
| RU94041246A (ru) | Способ лечения псориаза | |
| ATE261438T1 (de) | Produkte für körperhygiene basierend auf lapacho extrakte enthaltend quercetin, deren herstellung und verwendung | |
| RU94024337A (ru) | Антиметастатическое средство | |
| RU94016406A (ru) | Способ лечения рожистого воспаления | |
| TR199800904T2 (xx) | Yeni kinoksalindiyon t�revleri'nin �retimi ve ila�larda kullan�m� | |
| ATE334672T1 (de) | Ginkolide zur hemmung der membranexpression | |
| MY113450A (en) | Anellated b-carbolines | |
| NZ336633A (en) | The use of chitosans for the production of antithrush formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |